The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 2×
“The BCS is a scientific framework for classifying a drug substance based on its aqueous solubility and intestinal permeability (1).”
BackgroundSelf-citation(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Löbenberg, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00091-6 · Cited by 729
Fleisher, D., Li, C., Zhou, Y., Pao, L., & Karim, A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00004 · Cited by 506
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Yu, L. X., Lipka, E., Crison, J. R., & Amidon, G. L. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00009-9 · Cited by 335
Self-citationActive secretion and enterocytic drug metabolism barriers to drug absorption
Wacher, V. J., Salphati, L., & Benet, L. Z. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00127-s · Cited by 308
Wacher, V. J., Salphati, L., & Benet, L. Z. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00126-5 · Cited by 245
Yu, L., Bridgers, A., Polli, J., Vickers, A., Long, S., Roy, A., Winnike, R., & Coffin, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018939006780 · Cited by 225
Self-citationOberle, R. L., & Amidon, G. L. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061761 · Cited by 208
Self-citation
Cited by
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9511-1 · Cited by 1,191
Self-citationKhadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847
Self-citationDokoumetzidis, A., & Macheras, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.011 · Cited by 715
Wen, H., Jung, H., & Li, X. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9814-9 · Cited by 574
Drug delivery strategies for poorly water-soluble drugs
Fahr, A., & Liu, X. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.403 · Cited by 568
Bridging solubility between drug discovery and development
Di, L., Fish, P. V., & Mano, T. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.007 · Cited by 491
Dahan, A., Miller, J. M., & Amidon, G. L. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9144-x · Cited by 453
Self-citationCustodio, J. M., Wu, C.-Y., & Benet, L. Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.043 · Cited by 434
Jermain, S. V., Brough, C., & Williams, R. O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.051 · Cited by 431
Butler, J. M., & Dressman, J. B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22217 · Cited by 427
High throughput solubility measurement in drug discovery and development
Alsenz, J., & Kansy, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.007 · Cited by 412
Assessing the performance of amorphous solid dispersions
Newman, A., Knipp, G., & Zografi, G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23031 · Cited by 406
VERTZONI, M., DRESSMAN, J., BUTLER, J., HEMPENSTALL, J., & REPPAS, C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.002 · Cited by 358
Lipid-based formulations for oral administration of poorly water-soluble drugs
Mu, H., Holm, R., & Müllertz, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.054 · Cited by 328
Development of a new permeability assay using low‐efflux MDCKII cells
Di, L., Whitney‐Pickett, C., Umland, J. P., Zhang, H., Zhang, X., Gebhard, D. F., Lai, Y., Federico, J. J., Davidson, R. E., Smith, R., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22674 · Cited by 313
Müllertz, A., Ogbonna, A., Ren, S., & Rades, T. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01107.x · Cited by 295
Yazdanian, M., Briggs, K., Jankovsky, C., & Hawi, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016242.48642.71 · Cited by 290
Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery
Brough, C., & Williams, R. O. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.061 · Cited by 288
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Dahan, A., Miller, J. M., Hoffman, A., Amidon, G. E., & Amidon, G. L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22033 · Cited by 224
Self-citationMiller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200181v · Cited by 204
Self-citationThe BCS, BDDCS, and Regulatory Guidances
Chen, M.-L., Amidon, G. L., Benet, L. Z., Lennernas, H., & Yu, L. X. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0438-1 · Cited by 93
Self-citationAmidon, K. S., Langguth, P., Lennernäs, H., Yu, L., & Amidon, G. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.109 · Cited by 44
Self-citation(2009) · Scientific Research and Essays · doi:10.5897/sre.9000747 · Cited by 33
Mendes, C., Buttchevitz, A., Kruger, J. H., Kratz, J. M., Simões, C. M. O., de Oliveira Benedet, P., Oliveira, P. R., & Silva, M. A. S. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.015 · Cited by 31
Metadata
- Authors
- Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., & Hussain, A. S.
- Venue
- Pharmaceutical Research
- Published
- 2002-07
- Volume
- 19
- Issue
- 7
- Pages
- 921-925
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2129827408
- Cited by
- 571
- References
- 18
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.